Found 19 matching trials
Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer PHASE2 Background:
\- Enzalutamide is a well tolerated hormone therapy that is us...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer PHASE2 Background:
* Flutamide is an approved drug for prostate cancer that block...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Sequential Vaccinations in Prostate Cancer Patients PHASE1 Background:
" Adenocarcinoma of the prostate is the most common cancer dia...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer PHASE2 Vaccines made from a gene-modified virus may help the body build an effecti...
Show More Location
Baptist Cancer Institute
Learn More & Join Trial
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer PHASE2 Background:
Metastatic castrate-sensitive prostate cancer is cancer that h...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer PHASE1 Phase I trial to study the effectiveness of vaccine therapy in treating pat...
Show More Location
Massachusetts General Hospital Cancer Center
Learn More & Join Trial
PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Indiana University Cancer Center
Learn More & Join Trial
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer PHASE2 Background:
Some people with prostate cancer have a rise in prostate-speci...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer PHASE2 This randomized phase II trial studies how well docetaxel and prednisone wi...
Show More Location
Mayo Clinic in Florida
Learn More & Join Trial
Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial